| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-3223(99)00079-7 |
| P698 | PubMed publication ID | 10472424 |
| P50 | author | Stephan Arndt | Q43299366 |
| P2093 | author name string | Andreasen NC | |
| Nopoulos P | |||
| Heckel D | |||
| Corson PW | |||
| P2860 | cites work | "Perestroika" in the basal forebrain: opening the border between neurology and psychiatry | Q30446663 |
| Problems with ratio and proportion measures of imaged cerebral structures | Q33452567 | ||
| Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images | Q34061986 | ||
| Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia | Q34274456 | ||
| Risperidone in the treatment of schizophrenia | Q34719470 | ||
| Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients | Q34731441 | ||
| Image processing for the study of brain structure and function: problems and programs | Q36310040 | ||
| Neurobehavioral changes associated with caudate lesions | Q38483418 | ||
| Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures | Q41102237 | ||
| Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia | Q41168210 | ||
| The basal ganglia and cognitive pattern generators | Q41609628 | ||
| Schizophrenia, psychosis, and the basal ganglia | Q41690303 | ||
| Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial | Q42550364 | ||
| Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. | Q43405566 | ||
| Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. | Q45290072 | ||
| Longitudinal change in basal ganglia volume in patients with Huntington's disease | Q45293834 | ||
| Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function | Q45299001 | ||
| Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan | Q45304491 | ||
| A decrease in the size of the basal ganglia in children with fetal alcohol syndrome. | Q46386741 | ||
| Parkinsonism in neuroleptic-naive schizophrenic patients | Q46456244 | ||
| Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task | Q47293404 | ||
| Human striatum: Chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease | Q48119453 | ||
| Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study | Q48136032 | ||
| Measurement of brain structures with artificial neural networks: two- and three-dimensional applications. | Q48196344 | ||
| Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. | Q48274107 | ||
| Structural abnormalities in deficit and nondeficit schizophrenia | Q48365695 | ||
| Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations | Q48458665 | ||
| Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study | Q48539180 | ||
| Caudate hemorrhage | Q48594576 | ||
| Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography | Q48609948 | ||
| MRI abnormalities in tardive dyskinesia | Q48635421 | ||
| Limbic selectivity of clozapine | Q48636491 | ||
| Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioral measures | Q48648677 | ||
| Neurochemical architecture of the human striatum | Q48656419 | ||
| Magnetic resonance brain imaging in women with obsessive-compulsive disorder and trichotillomania. | Q48659991 | ||
| Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study | Q48768400 | ||
| The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography | Q48793944 | ||
| Neuropsychiatric implications of basal ganglia dysfunction | Q48799098 | ||
| A magnetic resonance imaging study of schizophrenia: brain structure and clinical symptoms | Q48802595 | ||
| Caudate nucleus area in drug-induced parkinsonism | Q48866743 | ||
| Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study | Q49068807 | ||
| Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study. | Q51017596 | ||
| Perceptual capacity, functions of the corpus striatum and schizophrenia | Q51339097 | ||
| The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. | Q52042140 | ||
| Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. | Q52210240 | ||
| Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. | Q52212490 | ||
| Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol | Q70835005 | ||
| Reduced caudate nucleus volume in obsessive-compulsive disorder | Q72181804 | ||
| Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine | Q72540541 | ||
| Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus | Q72574203 | ||
| Neuroleptic treatment and caudate plasticity | Q72618486 | ||
| Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs | Q72692455 | ||
| Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen | Q72815743 | ||
| Changes in caudate volume with neuroleptic treatment | Q72824681 | ||
| P4510 | describes a project that uses | artificial neural network | Q192776 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| patient | Q181600 | ||
| artificial neural network | Q192776 | ||
| P304 | page(s) | 712-720 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network | |
| P478 | volume | 46 |
| Q48499474 | A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naïve, newly diagnosed schizophrenia. |
| Q24657354 | A review of MRI findings in schizophrenia |
| Q35776852 | Abnormal hippocampal-thalamic white matter tract development and positive symptom course in individuals at ultra-high risk for psychosis |
| Q37470765 | An elliptic PDE approach for shape characterization |
| Q34151554 | Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis. |
| Q48607713 | Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects |
| Q48886754 | Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia |
| Q44278018 | Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient |
| Q30958760 | Changes in brain structure caused by neuroleptic medication |
| Q37445575 | Characterizing the shape of anatomical structures with Poisson's equation |
| Q36148740 | Cortical gyrification in velo-cardio-facial (22q11.2 deletion) syndrome: a longitudinal study |
| Q83044640 | Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry |
| Q33425487 | Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings |
| Q48960835 | Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment. |
| Q36983864 | Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response |
| Q34415975 | Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. |
| Q36487731 | High order linguistic features such as ambiguity processing as relevant diagnostic markers for schizophrenia |
| Q33712210 | Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia |
| Q36901537 | Impaired implicit learning in schizophrenia |
| Q30459370 | Increased cell proliferation in the rat anterior cingulate cortex following neonatal hypoxia: relevance to schizophrenia |
| Q36790073 | Larger putamen size in antipsychotic-naïve individuals with schizotypal personality disorder |
| Q36569499 | Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type |
| Q33678009 | MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder |
| Q48571124 | Morphology of the ventral frontal cortex in schizophrenia: relationship with social dysfunction |
| Q49109228 | Movement sequencing abilities and basal ganglia morphology in first-episode schizophrenia |
| Q31139428 | Neural bases of dysphoria in early Huntington's disease |
| Q35919608 | Neurological soft signs in schizophrenia - The past, the present and the future |
| Q36045493 | Predictors and markers of clozapine response |
| Q48633626 | Quantification of errors in volume measurements of the caudate nucleus using magnetic resonance imaging |
| Q37699352 | Reduced binding potential of GABA-A/benzodiazepine receptors in individuals at ultra-high risk for psychosis: an [18F]-fluoroflumazenil positron emission tomography study |
| Q51984392 | Reduced white matter volume of the caudate nucleus in patients with schizophrenia. |
| Q37400450 | Reduction of caudate nucleus volumes in neuroleptic-naïve female subjects with schizotypal personality disorder |
| Q37258056 | Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia |
| Q30918894 | Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment |
| Q34605931 | Shape abnormalities of caudate nucleus in schizotypal personality disorder |
| Q30711211 | Similar and different gray matter deficits in schizophrenia patients and their unaffected biological relatives |
| Q37374981 | Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis |
| Q35728197 | Structural analysis of the basal ganglia in schizophrenia |
| Q33606379 | Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. |
| Q31149161 | Structural neuroimaging of the basal ganglia in schizophrenic patients: a review |
| Q44374816 | Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo |
| Q36661326 | Subcortical neuromorphometry in schizophrenia spectrum and bipolar disorders |
| Q44193616 | The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states |
Search more.